The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of overweight, obesity, and post-treatment weight changes on occupational reintegration of breast cancer (BC) survivors.
 
Antonio Di Meglio
No Relationships to Disclose
 
Gwenn Menvielle
No Relationships to Disclose
 
Agnes Dumas
No Relationships to Disclose
 
Arnauld S. Gbenou
No Relationships to Disclose
 
Thomas Bovagnet
No Relationships to Disclose
 
Elise Martin
No Relationships to Disclose
 
Arlindo R. Ferreira
No Relationships to Disclose
 
Laurence Vanlemmens
No Relationships to Disclose
 
Olivier Arsene
No Relationships to Disclose
 
Mahmoud Ibrahim
No Relationships to Disclose
 
Johanna Wassermann
No Relationships to Disclose
 
Anne-Laure Martin
No Relationships to Disclose
 
Jerome Lemonnier
No Relationships to Disclose
 
Lucia Del Mastro
Honoraria - Eisai; Ipsen; Lilly; MSD; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - Lilly; Roche
Travel, Accommodations, Expenses - Celgene; Pfizer; Roche
 
Lee Jones
Stock and Other Ownership Interests - Pacylex
 
Ann H. Partridge
No Relationships to Disclose
 
Jennifer A. Ligibel
No Relationships to Disclose
 
Fabrice Andre
Research Funding - AstraZeneca (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Novartis; Roche
 
Stefan Michiels
Consulting or Advisory Role - Genticel; Hexal; IDDI; Johnson & Johnson; Mabxience; QuintilesIMS; Roche
Patents, Royalties, Other Intellectual Property - Patent pending of a prognostic gene score in early breast cancer: WO2017EP66533
 
Ines Maria Vaz Duarte Luis
Honoraria - AstraZeneca; Kephren; Novartis
Consulting or Advisory Role - Ipsen